Geographical mapping of a multifocal thyroid tumour using genetic alteration analysis & miRNA profiling

Molecular Cancer

Volumn 7, Issue , 2008, Pages

  Aherne, Sinéad T ^a   Smyth, Paul C ^a   Flavin, Richard J ^a   Russell, Susan M ^c   Denning, Karen M ^a   Li, Jing Huan ^a   Guenther, Simone M ^b   O'Leary, John J ^a   Sheils, Orla M ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b APPLIED BIOSYSTEMS   (United States)

^c ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CYTOKERATIN; MICRORNA; PROTEIN P53; PROTEIN PATCHED 1; TUMOR MARKER;

ANIMAL CELL; CLONAL VARIATION; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION PROFILING; GENE MAPPING; GENE MUTATION; GENE REARRANGEMENT; GENETIC ANALYSIS; GENETIC DISORDER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROENVIRONMENT; NONHUMAN; PAPILLARY THYROID CARCINOMA; PATHOLOGICAL ANATOMY; PHENOTYPIC VARIATION; PROTEIN EXPRESSION; REVIEW; THYROID CARCINOMA; TUMOR CLASSIFICATION; ARTICLE; CLASSIFICATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; MUTATION; PATHOLOGY; THYROID TUMOR; UPREGULATION;

DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; MICRORNAS; MUTATION; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 58149335076     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-7-89     Document Type: Review

References (43)

1. Segev DL Umbricht C Zeiger MA Molecular pathogenesis of thyroid cancer Surg Oncol 2003, 12:69-90. 10.1016/S0960-7404(03)00037-9 12946479
2. DeLellis RA Pathology and genetics of thyroid carcinoma J Surg Oncol 2006, 94:662-669. 10.1002/jso.20700 17131411
3. Xing M BRAF mutation in thyroid cancer Endocr Relat Cancer 2005, 12:245-262. 10.1677/erc.1.0978 15947100
4. Smyth P Finn S Cahill S O'Regan E Flavin R O'Leary JJ Sheils O ret/PTC and BRAF act as distinct molecular, time-dependant triggers in a sporadic Irish cohort of papillary thyroid carcinoma Int J Surg Pathol 2005, 13:1-8. 10.1177/106689690501300101 15735849
5. Finn SP Smyth P O'Leary J Sweeney EC Sheils O Ret/PTC chimeric transcripts in an Irish cohort of sporadic papillary thyroid carcinoma J Clin Endocrinol Metab 2003, 88:938-941. 10.1210/jc.2002-021239 12574236
6. Thomas GA Bunnell H Cook HA Williams ED Nerovnya A Cherstvoy ED Tronko ND Bogdanova TI Chiappetta G Viglietto G Pentimalli F Salvatore G Fusco A Santoro M Vecchio G High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: A strong correlation between RET/PTC3 and the solid-follicular variant J Clin Endocrinol Metab 1999, 84:4232-4238. 10.1210/jc.84.11.4232 10566678
7. Takano T Ito Y Hirokawa M Yoshida H Miyauchi A BRAF V600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas Br J Cancer 2007, 96:1549-1553. 10.1038/sj.bjc.6603764 17453004
8. Giannini R Ugolini C Lupi C Proietti A Elisei R Salvatore G Berti P Materazzi G Miccoli P Santoro M Basolo F The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma J Clin Endocrinol Metab 2007, 92:3511-3516. 10.1210/jc.2007-0594 17535994
9. Wang HM Huang YW Huang JS Wang CH Kok VC Hung CM Chen HM Tzen CY Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma Ann Surg Oncol 2007, 14:3011-3018. 10.1245/s10434-007-9418-4 17638058
10. McCarthy RP Wang M Jones TD Strate RW Cheng L Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas Clin Cancer Res 2006, 12:2414-2418. 10.1158/1078-0432.CCR-05-2818 16638846
11. Park SY Park YJ Lee YJ Lee HS Choi SH Choe G Jang HC Park SH Park do J Cho BY Analysis of differential BRAF(V600E) mutational status in multifocal papillary thyroid carcinoma: Evidence of independent clonal origin in distinct tumor foci Cancer 2006, 107:1831-1838. 10.1002/ cncr.22218 16983703
12. Quiros RM Ding HG Gattuso P Prinz RA Xu X Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations Cancer 2005, 103:2261-2268. 10.1002/cncr.21073 15880523
13. Shattuck TM Westra WH Ladenson PW Arnold A Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma N Engl J Med 2005, 352:2406-2412. 10.1056/NEJMoa044190 15944425
14. Begum S Rosenbaum E Henrique R Cohen Y Sidransky D Westra WH BRAF mutations in anaplastic thyroid carcinoma: Implications for tumor origin, diagnosis and treatment Mod Pathol 2004, 17:1359-1363. 10.1038/ modpathol.3800198 15195111
15. Sugg SL Ezzat S Rosen IB Freeman JL Asa SL Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia J Clin Endocrinol Metab 1998, 83:4116-4122. 10.1210/jc.83.11.4116 9814501
16. Carthew RW Gene regulation by microRNAs Curr Opin Genet Dev 2006, 16:203-208. 10.1016/j.gde.2006.02.012 16503132
17. Griffiths-Jones S Grocock RJ van Dongen S Bateman A Enright AJ miRBase: microRNA sequences, targets and gene nomenclature Nucleic Acids Res 2006, 34:D140-144. 1347474 16381832 10.1093/nar/gkj112
18. Cummins JM Velculescu VE Implications of micro-RNA profiling for cancer diagnosis Oncogene 2006, 25:6220-6227. 10.1038/sj.onc.1209914 17028602
19. He H Jazdzewski K Li W Liyanarachchi S Nagy R Volinia S Calin GA Liu CG Franssila K Suster S Kloos RT Croce CM de la Chapelle A The role of microRNA genes in papillary thyroid carcinoma Proc Natl Acad Sci USA 2005, 102:19075-19080. 1323209 16365291 10.1073/pnas.0509603102
20. Pallante P Visone R Ferracin M Ferraro A Berlingieri MT Troncone G Chiappetta G Liu CG Santoro M Negrini M Croce CM Fusco A MicroRNA deregulation in human thyroid papillary carcinomas Endocr Relat Cancer 2006, 13:497-508. 10.1677/erc.1.01209 16728577
21. Nikiforova MN Tseng GC Steward D Diorio D Nikiforov YE MicroRNA Expression Profiling of Thyroid Tumors: Biological Significance and Diagnostic Utility J Clin Endocrinol Metab 2008: 18270258
22. Mazzaferri EL Jhiang SM Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer Am J Med 1994, 97:418-428. 10.1016/0002-9343(94)90321-2 7977430
23. Chen C Ridzon DA Broomer AJ Zhou Z Lee DH Nguyen JT Barbisin M Xu NL Mahuvakar VR Andersen MR Lao KQ Livak KJ Guegler KJ Real-time quantification of microRNAs by stem-loop RT-PCR Nucleic Acids Res 2005, 33:e179. 1292995 16314309 10.1093/nar/gni178
24. Rosai JCM Delellis RA Tumors of the Thyroid Gland Atlas of Tumor Pathology Washington, DC: Armed Forces Institute of Pathology 1992
25. Lao K Xu NL Yeung V Chen C Livak KJ Straus NA Multiplexing RT-PCR for the detection of multiple miRNA species in small samples Biochem Biophys Res Commun 2006, 343:85-89. 10.1016/j.bbrc.2006.02.106 16529715
26. Megraw M Sethupathy P Corda B Hatzigeorgiou AG miRGen: A database for the study of animal microRNA genomic organization and function Nucleic Acids Res 2007, 35:D149-155. 1669779 17108354 10.1093/nar/gkl904
27. Nisolle M Gillerot S Casanas-Roux F Squifflet J Berliere M Donnez J Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy Hum Reprod 1999, 14:2844-2850. 10.1093/humrep/ 14.11.2844 10548634
28. Livak KJ Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 2001, 25:402-408. 10.1006/meth.2001.1262 11846609
29. Dalmay T Edwards DR MicroRNAs and the hallmarks of cancer Oncogene 2006, 25:6170-6175. 10.1038/sj.onc.1209911 17028596
30. Volinia S Calin GA Liu CG Ambs S Cimmino A Petrocca F Visone R Iorio M Roldo C Ferracin M Prueitt RL Yanaihara N Lanza G Scarpa A Vecchione A Negrini M Harris CC Croce CM A microRNA expression signature of human solid tumors defines cancer gene targets Proc Natl Acad Sci USA 2006, 103:2257-2261. 1413718 16461460 10.1073/pnas.0510565103
31. Cahill S Smyth P Finn SP Denning K Flavin R O'Regan EM Li J Potratz A Guenther SM Henfrey R O'Leary JJ Sheils O Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model Mol Cancer 2006, 5:70. 1713250 17156473 10.1186/1476-4598-5-70
32. Cahill S Smyth P Denning K Flavin R Li J Potratz A Guenther SM Henfrey R O'Leary JJ Sheils O Effect of BRAFV600E mutation on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model Mol Cancer 2007, 6:21. 1831483 17355635 10.1186/1476-4598-6-21
33. He L He X Lim LP de Stanchina E Xuan Z Liang Y Xue W Zender L Magnus J Ridzon D Jackson AL Linsley PS Chen C Lowe SW Cleary MA Hannon GJ A microRNA component of the p53 tumour suppressor network Nature 2007, 447:1130-1134. 10.1038/nature05939 17554337
34. Chuang JC Jones PA Epigenetics and microRNAs Pediatr Res 2007, 61:24R-29R. 10.1203/pdr.0b013e3180457684 17413852
35. Cho RJ Campbell MJ Transcription, genomes, function Trends Genet 2000, 16:409-415. 10.1016/S0168-9525(00)02065-5 10973070
36. Turner HE Harris AL Melmed S Wass JA Angiogenesis in endocrine tumors Endocr Rev 2003, 24:600-632. 10.1210/er.2002-0008 14570746
37. Are C Shaha AR Anaplastic thyroid carcinoma: Biology, pathogenesis, prognostic factors, and treatment approaches Ann Surg Oncol 2006, 13:453-464. 10.1245/ASO.2006.05.042 16474910
38. Garcia-Jimenez C Santisteban P TSH signalling and cancer Arq Bras Endocrinol Metabol 2007, 51:654-671. 17891229
39. Kikuchi A Tumor formation by genetic mutations in the components of the Wnt signaling pathway Cancer Sci 2003, 94:225-229. 10.1111/ j.1349-7006.2003.tb01424.x 12824913
40. Abbosh PH Nephew KP Multiple signaling pathways converge on beta-catenin in thyroid cancer Thyroid 2005, 15:551-561. 10.1089/thy.2005.15.551 16029121
41. Benjamin JM Nelson WJ Bench to bedside and back again: Molecular mechanisms of alpha-catenin function and roles in tumorigenesis Semin Cancer Biol 2008, 18:53-64. 10.1016/j.semcancer.2007.08.003 17945508
42. Smyth P Sheils O Finn S Martin C O'Leary J Sweeney EC Real-time quantitative analysis of E-cadherin expression in ret/PTC-1-activated thyroid neoplasms Int J Surg Pathol 2001, 9:265-272. 10.1177/ 106689690100900402 12574841
43. Hassan I Wunderlich A Slater E Hoffmann S Celik I Zielke A Antisense p53 decreases production of VEGF in follicular thyroid cancer cells Endocrine 2006, 29:409-412. 10.1385/ENDO:29:3:409 16943578